What is Global mRNA Sequencing Market?
The Global mRNA Sequencing Market is a rapidly evolving field that has gained significant traction in recent years. mRNA sequencing, also known as transcriptome sequencing, is a technology that uses next-generation sequencing (NGS) to reveal the presence and quantity of RNA in a biological sample at a given moment. This technique is primarily used to analyze the constantly changing cellular transcriptome, which is the set of all RNA molecules, including mRNA, rRNA, tRNA, and other non-coding RNA transcribed in one cell or a population of cells. The global mRNA sequencing market is driven by the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing need for robust, rapid, and accurate diagnostic tests. The market also benefits from the rising prevalence of genetic disorders and chronic diseases, the growing application areas of genomics, and the increasing R&D investment in the pharmaceutical and biotechnology sector.
PCR, Microarray, Sequencing in the Global mRNA Sequencing Market:
PCR, Microarray, and Sequencing are three key technologies used in the Global mRNA Sequencing Market. PCR, or Polymerase Chain Reaction, is a method widely used in molecular biology to make several copies of a specific DNA segment. It is highly accurate and can amplify a single or few copies of a piece of DNA across several orders of magnitude, generating millions or more copies of a particular DNA sequence. Microarray, on the other hand, is a laboratory tool used to detect the expression of thousands of genes at the same time. DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. Sequencing is the process of determining the precise order of nucleotides within a DNA molecule. It includes any method or technology that is used to determine the order of the four bases: adenine, guanine, cytosine, and thymine. The advent of rapid DNA sequencing methods has greatly accelerated biological and medical research and discovery.
Pharmaceutical and Biotechnology, Academic Research and Government Institutes, Hospitals and Diagnostic Centers in the Global mRNA Sequencing Market:
The Global mRNA Sequencing Market finds its usage in various areas such as Pharmaceutical and Biotechnology, Academic Research and Government Institutes, Hospitals, and Diagnostic Centers. In the Pharmaceutical and Biotechnology sector, mRNA sequencing is used for drug discovery and development, personalized medicine, and therapeutic drug monitoring. In Academic Research and Government Institutes, it is used for studying gene expression, genetic variation, and other molecular biology research. Hospitals and Diagnostic Centers use mRNA sequencing for diagnostic testing, prognostic testing, and monitoring patient response to treatment. The use of mRNA sequencing in these areas has revolutionized the way we understand, diagnose, and treat various diseases. It has also opened up new avenues for research and development, leading to the discovery of new drugs and therapies.
Global mRNA Sequencing Market Outlook:
Looking at the market outlook, the Global mRNA Sequencing Market was valued at a substantial US$ 2810 million in 2023. The market is projected to experience a significant growth, reaching an impressive value of US$ 8813.4 million by 2030. This indicates a robust Compound Annual Growth Rate (CAGR) of 17.7% during the forecast period from 2024 to 2030. This growth can be attributed to the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing need for robust, rapid, and accurate diagnostic tests. The market also benefits from the rising prevalence of genetic disorders and chronic diseases, the growing application areas of genomics, and the increasing R&D investment in the pharmaceutical and biotechnology sector.
| Report Metric | Details |
| Report Name | mRNA Sequencing Market |
| Accounted market size in 2023 | US$ 2810 million |
| Forecasted market size in 2030 | US$ 8813.4 million |
| CAGR | 17.7% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
